Original StudyImprovement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Under a Creative Commons license
open access
Keywords
Bruton's tyrosine kinase
Disease-related symptoms
Fatigue
Quality of life
Relapsed/refractory CLL/SLL
Cited by (0)
© 2018 The Authors. Published by Elsevier Inc.